Opiophobia in Adults With Advanced Cancer
NCT07093567 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 50
Last updated 2026-02-18
Summary
To explore the barriers and fears related to use of opioids among a population of adult outpatients with advanced cancer who continue to experience pain after receiving a prescription for opioid analgesia and hypothesized associations among opiophobia, anxiety, depression, pain intensity, pain interference, and opioid medication adherence.
Conditions
Sponsors & Collaborators
-
M.D. Anderson Cancer Center
lead OTHER
Principal Investigators
-
Eileen Hacker, PHD, RN · M.D. Anderson Cancer Center
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-08-01
- Primary Completion
- 2029-01-01
- Completion
- 2031-01-01
Countries
- United States
Study Locations
More Related Trials
-
Individualized Pharmaceutical-care for Inpatients With Cancer Pain
NCT03455023 ·Status: UNKNOWN ·Phase: NA
-
Real World Study of Oxycodone Sustained-release Tablets for Patients With Moderate to Severe Cancer Pain
NCT05962294 ·Status: UNKNOWN
-
Clinical Data Collection in Studying Clinical Factors Associated With Post-Surgery Chronic Opioid Use in Patients With Head and Neck Cancers
NCT03888651 ·Status: ACTIVE_NOT_RECRUITING
-
Inhaled Cannabinoids Versus Immediate-release Oral Opioids for the Management of Breakthrough Cancer Pain
NCT03564548 ·Status: UNKNOWN ·Phase: PHASE2
-
Morphine Versus Methadone As First Line Strong Opioid for Cancer Pain
NCT00634010 ·Status: TERMINATED ·Phase: PHASE3
-
A Study to Assess the Safety and Tolerability of Oxycodone Hydrochloride 50mg/mL Administered as an Infusion
NCT00626600 ·Status: TERMINATED ·Phase: PHASE3
-
Stress and Opioid Misuse Risk: The Role of Endogenous Opioid and Endocannabinoid Mechanisms
NCT05142267 ·Status: RECRUITING ·Phase: NA
-
Effect of Opioid Infusion Rate on Abuse Liability Potential of Intravenous Hydromorphone for Cancer Pain
NCT04296305 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
Opioid and Cannabinoid Pharmacokinetic Interactions
NCT00308555 ·Status: COMPLETED ·Phase: PHASE1
-
Opioid Titration Order Sheet or Standard Care in Treating Patients With Cancer Pain
NCT00666211 ·Status: COMPLETED ·Phase: PHASE3
-
A Brief Intervention for Patients on Opioids for Acute Pain
NCT05658926 ·Status: COMPLETED ·Phase: NA
-
Opioids With or Without Olanzapine in Treating Patients With Moderate to Severe Cancer Pain
NCT00737191 ·Status: WITHDRAWN ·Phase: NA
-
3D1002 in Combination With Oxycodone Hydrochloride Sustained-release Tablets in Patients With Moderate to Severe Cancer Pain
NCT05265052 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Validation of a Screening Scale for Misuse of Opioid Analgesics
NCT05761587 ·Status: UNKNOWN
-
Opiate-Induced Tolerance & Hyperalgesia in Pain Patients
NCT00246532 ·Status: COMPLETED ·Phase: PHASE4
-
Does Medical Cannabis Reduce Opioid Use in Adults With Pain
NCT04308148 ·Status: COMPLETED
-
Validation and Assessment of Patient Adherence to Opioids for Cancer Pain Using MMAS 8 Pain Clinic
NCT02804477 ·Status: COMPLETED
-
Methadone, Morphine, or Oxycodone in Treating Pain in Patients With Cancer
NCT00726830 ·Status: TERMINATED ·Phase: NA
-
A Comparison of the Perception of a Needle Injection Pain Between Cancer Patients Receiving Opioid Therapy Versus Opioid-naive Patients
NCT01704469 ·Status: COMPLETED ·Phase: NA
-
Opioid Rotation Versus Combination for Chronic Uncontrolled Cancer Pain
NCT00478101 ·Status: COMPLETED ·Phase: PHASE2
-
Naldemedine in Clinical Practice in Cancer Patients With Opioid Induced CONstipation: Clinical Outcomes and Patient Experience
NCT07231796 ·Status: RECRUITING
-
The Experiences of People Prescribed Opioid Pain Medicines
NCT04888897 ·Status: COMPLETED
-
Cessation of Long-term Opioid Therapy in Chronic Pain Patients
NCT02132221 ·Status: TERMINATED ·Phase: NA
-
Sensory Effects of Oral Opioid Treatment in Patients With Chronic Low Back Pain
NCT02824276 ·Status: COMPLETED ·Phase: PHASE1
-
Interdisciplinary Interventions to Address Pain Management Among Head and Neck Cancer Patients
NCT05077072 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2